Robert G Moses Selected Research

Metformin (Glucophage)

10/2018	A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes.
9/2016	A randomized clinical trial evaluating the safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control.
1/2015	Dipeptidyl peptidase-4 inhibitors in triple oral therapy regimens in patients with type 2 diabetes mellitus.
5/2010	Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update.
5/2010	Combination therapy for patients with Type 2 diabetes: repaglinide in combination with metformin.
3/2008	Achieving glycosylated hemoglobin targets using the combination of repaglinide and metformin in type 2 diabetes: a reanalysis of earlier data in terms of current targets.
11/2007	Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert G Moses Research Topics

Disease

10	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2020 - 04/2002
9	Type 2 Diabetes Mellitus (MODY) 09/2016 - 10/2004
4	Hypoglycemia (Reactive Hypoglycemia) 10/2018 - 10/2004
3	Body Weight (Weight, Body) 10/2018 - 01/2014
2	Hyperglycemia 10/2018 - 05/2010
1	Metabolic Diseases (Metabolic Disease) 10/2018
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 10/2018
1	Obesity 10/2018
1	Edema (Dropsy) 09/2016
1	Gestational Weight Gain 09/2015
1	Weight Gain 01/2015
1	Infections 01/2014
1	Urinary Tract Infections (Urinary Tract Infection) 01/2014
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2012
1	Insulin Resistance 05/2010
1	Diabetes Mellitus 11/2007

Drug/Important Bio-Agent (IBA)

7	Metformin (Glucophage)FDA LinkGeneric 10/2018 - 11/2007
6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 04/2002
6	Insulin (Novolin)FDA Link 10/2018 - 10/2004
3	repaglinide (Prandin)FDA Link 05/2010 - 03/2008
2	Sitagliptin Phosphate (Januvia)FDA Link 09/2016 - 01/2015
2	Hypoglycemic Agents (Hypoglycemics)IBA 09/2016 - 10/2004
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2015 - 01/2014
1	Glyburide (Glibenclamide)FDA LinkGeneric 10/2018
1	Pioglitazone (Actos)FDA Link 09/2016
1	MicronutrientsIBA 09/2015
1	VildagliptinIBA 01/2015
1	saxagliptin FDA Link 01/2015
1	alogliptinIBA 01/2015
1	LinagliptinIBA 01/2015
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2015
1	dapagliflozinIBA 01/2014
1	CanagliflozinIBA 01/2014
1	CarbohydratesIBA 02/2013
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2008
1	InsulinsIBA 11/2007
1	Blood Glucose (Blood Sugar)IBA 11/2007
1	insulin glulisine FDA Link 10/2004

Therapy/Procedure

8	Glycemic Control 10/2018 - 10/2004
7	Therapeutics 01/2015 - 10/2004
1	Injections 11/2007